Industry ranking
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2025 - 31 Dec 2025 | 02 Feb 2026 | 48 | 27% | 56% | 17% | 81% |
| 01 Jan 2025 - 30 Jun 2025 | 29 Jul 2025 | 49 | 27% | 56% | 17% | 79% |
| 01 Jul 2024 - 31 Dec 2024 | 27 Jan 2025 | 44 | 28% | 60% | 12% | 79% |
| 01 Jan 2024 - 30 Jun 2024 | 06 Aug 2024 | 63 | 24% | 52% | 24% | 76% |
| 01 Jul 2023 - 31 Dec 2023 | 26 Jan 2024 | 60 | 65% | 11% | 24% | 28% |
| 01 Jan 2023 - 30 Jun 2023 | 26 Jul 2023 | 65 | 62% | 11% | 26% | 34% |
| 01 Jul 2022 - 31 Dec 2022 | 22 May 2023 | 23 | 67% | 10% | 22% | 24% |
| 01 Jan 2022 - 30 Jun 2022 | 22 May 2023 | 64 | 64% | 9% | 27% | 27% |
| 01 Jul 2021 - 31 Dec 2021 | 21 Jan 2022 | 71 | 57% | 14% | 29% | 36% |
| 01 Jan 2021 - 30 Jun 2021 | 23 Jul 2021 | 62 | 64% | 10% | 26% | 33% |
| 01 Jul 2020 - 31 Dec 2020 | 29 Jan 2021 | 53 | 17% | 63% | 20% | 87% |
| 01 Jan 2020 - 30 Jun 2020 | 30 Jul 2020 | 61 | 28% | 50% | 22% | 79% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 55 | 64% | 16% | 20% | 45% |
| 01 Jan 2019 - 30 Jun 2019 | 30 Jul 2019 | 48 | 63% | 16% | 21% | 45% |
| 01 Jul 2018 - 31 Dec 2018 | 11 Apr 2019 | 52 | 62% | 17% | 21% | 43% |
| 01 Jan 2018 - 30 Jun 2018 | 12 Nov 2018 | 38 | 65% | 19% | 16% | 47% |
This information is as reported by the business, and responses are in their own words.
Standard payment terms
most frequent 3rd party payment terms are on 30 days.
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
60
Where invoices received from suppliers do not match expected values or units as per issued purchase orders, contact is made to discuss and amend invoices as appropriate with a view to swift resolution of disputes.
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Fresenius Kabi Limited is a UK-registered company based in Runcorn, Cheshire, whose registered business activity is the manufacture of pharmaceutical preparations. Incorporated in 1987, it has traded under several previous names, including Boots Hospital Products Limited, Kendall Laboratories Limited, FL (Manufacturing) Limited and Fresenius Limited, before adopting its current name. It remains an active company on the UK register, filing accounts and confirmation statements annually. As its SIC classification indicates, the entity's registered function is pharmaceutical manufacturing, consistent with its place within the wider Fresenius Kabi group, which is associated with production and supply of clinical and pharmaceutical products.
Generated from the company's website and Companies House records. Sources: find-and-update.company-information.service.gov.uk